Volumetric Modulated Arc Therapy Decreases Incidence of Acute Rectal Toxicity in the Treatment of Low- and Intermediate-Risk Prostate Cancer

被引：1
作者：
Dominello, M. [1 ]
Ku, K. [1 ]
Chen, G. [1 ]
Tait, L. [1 ]
Snyder, M. [1 ,2 ]
McSpadden, E. [1 ]
Maier, J. [1 ,2 ]
Miller, S. [1 ]
Konski, A. [1 ]
机构：
[1] Wayne State Univ, Detroit, MI USA
[2] Karmanos Canc Ctr, Detroit, MI USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.964
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S365 / S365
页数：1
相关论文
共 50 条
  • [1] RECTAL TOXICITY IN MODERATE HYPOFRACTIONATION PROSTATE CANCER WITH VOLUMETRIC MODULATED ARC THERAPY
    Ricchetti, Francesco
    Fersino, Sergio
    Mazzola, Rosario
    Levra, Niccolo Giaj
    Fiorentino, Alba
    Naccarato, Stefania
    Sicignano, Gianluisa
    Ruggieri, Ruggero
    Cavalleri, Stefano
    Alongi, Filippo
    ANTICANCER RESEARCH, 2015, 35 (06) : 3626 - 3627
  • [2] Management of low- and intermediate-risk prostate cancer
    van der Poel, Henk
    Klotz, Laurence
    Stief, Christian G.
    WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 905 - 906
  • [3] Management of low- and intermediate-risk prostate cancer
    Henk van der Poel
    Laurence Klotz
    Christian G. Stief
    World Journal of Urology, 2015, 33 : 905 - 906
  • [4] Longitudinal regret after treatment for low- and intermediate-risk prostate cancer
    Hurwitz, Lauren M.
    Cullen, Jennifer
    Kim, Daniel J.
    Elsamanoudi, Sally
    Hudak, Jane
    Colston, Maryellen
    Travis, Judith
    Kuo, Huai-Ching
    Rice, Kevin R.
    Porter, Christopher R.
    Rosner, Inger L.
    CANCER, 2017, 123 (21) : 4252 - 4258
  • [5] Current focal therapies for the treatment of low- and intermediate-risk prostate cancer
    Malorgio, Antonio
    ASIAN JOURNAL OF ANDROLOGY, 2024, 26 (06): : 592 - 594
  • [6] Pure Hypofractionated Radiotherapy for the Treatment of Low- to Intermediate-Risk Prostate Cancer
    Stephens, R.
    Gopaul, D.
    Panjwani, D.
    Lock, M.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S732 - S732
  • [7] Active surveillance in low- and intermediate-risk prostate cancer
    Cerbone, Linda
    Regine, Giovanni
    Calabro, Fabio
    ASIAN JOURNAL OF ANDROLOGY, 2024, 26 (06): : 582 - 583
  • [8] Testosterone kinetics after proton therapy for low- and intermediate-risk prostate cancer
    Nichols, Romaine Charles
    Morris, Christopher G.
    Hoppe, Bradford S.
    Henderson, Randal H.
    Mendenhall, William M.
    Li, Zuofeng
    Williams, Christopher R.
    Costa, Joseph A.
    Harris, Stephanie
    Mendenhall, Nancy Price
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [9] Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints
    Meier, Robert M.
    Bloch, Daniel A.
    Cotrutz, Cristian
    Beckman, Alan C.
    Henning, George T.
    Woodhouse, Shermian A.
    Williamson, Shirnett K.
    Mohideen, Najeeb
    Dombrowski, John J.
    Hong, Robert L.
    Brachman, David G.
    Linson, Patrick W.
    Kaplan, Irving D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (02): : 296 - 303
  • [10] Toxicity and Quality of Life After Hypofractionated Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
    Seymour, Z. A.
    Chang, A.
    Roach, M.
    Gottschalk, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S604 - S604
12345